🇺🇸 FDA
Patent

US 12128013

Toxic aldehyde related diseases and treatment

granted A61KA61K31/13A61K31/137

Quick answer

US patent 12128013 (Toxic aldehyde related diseases and treatment) held by Aldeyra Therapeutics, Inc. expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aldeyra Therapeutics, Inc.
Grant date
Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/13, A61K31/137, A61K31/197, A61K31/423